These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 15951293

  • 1. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Bernard M, Cartron G, Rachieru P, LeMevel A, Branger B, Le Maignan C, Berthou C, Ghandour C, Delwail V, Milpied N, Cassasus P, Celigny PS, Guyotat D, Lamy T, Desablens B, French GOELAMS Group.
    Haematologica; 2005 Jun; 90(6):802-9. PubMed ID: 15951293
    [Abstract] [Full Text] [Related]

  • 2. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P.
    J Clin Oncol; 2003 Jun 01; 21(11):2115-22. PubMed ID: 12775737
    [Abstract] [Full Text] [Related]

  • 4. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr 01; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.
    Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, LeBlanc M, Carlin S, Chase E, Fisher RI.
    N Engl J Med; 1998 Jul 02; 339(1):21-6. PubMed ID: 9647875
    [Abstract] [Full Text] [Related]

  • 6. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
    Huang HQ, Lin XB, Pan ZH, Bu Q, Gao Y, Wang BF, Cai QQ, Xia ZJ, Xu RH, Jiang WQ, Guan ZZ.
    Zhonghua Zhong Liu Za Zhi; 2007 May 02; 29(5):391-5. PubMed ID: 17892140
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr 02; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 8. Localized stage I-IE aggressive non-Hodgkin's lymphoma (NHL): results of prospective study with multimodality therapeutic approach.
    De Sanctis V, Martelli M, Anticoli AP, Caronna R, Chirletti P, Giovannini M, Santarelli M, Enrici RM, Mandelli F.
    Anticancer Res; 2001 Apr 02; 21(6A):4169-72. PubMed ID: 11911313
    [Abstract] [Full Text] [Related]

  • 9. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
    Verdonck LF, van Putten WL, Hagenbeek A, Schouten HC, Sonneveld P, van Imhoff GW, Kluin-Nelemans HC, Raemaekers JM, van Oers RH, Haak HL.
    N Engl J Med; 1995 Apr 20; 332(16):1045-51. PubMed ID: 7898521
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.
    Horning SJ, Weller E, Kim K, Earle JD, O'Connell MJ, Habermann TM, Glick JH.
    J Clin Oncol; 2004 Aug 01; 22(15):3032-8. PubMed ID: 15210738
    [Abstract] [Full Text] [Related]

  • 11. A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.
    Shikama N, Oguchi M, Isobe K, Nakamura K, Tamaki Y, Hasegawa M, Kodaira T, Sasaki S, Kagami Y, Japan Radiation Oncology Group (JAROG).
    Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):217-22. PubMed ID: 16814951
    [Abstract] [Full Text] [Related]

  • 12. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N.
    Ann Hematol; 2005 Apr 01; 84(4):223-6. PubMed ID: 15042316
    [Abstract] [Full Text] [Related]

  • 13. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr 01; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 14. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF.
    Zhonghua Zhong Liu Za Zhi; 2006 Jan 01; 28(1):58-61. PubMed ID: 16737624
    [Abstract] [Full Text] [Related]

  • 15. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
    Li YH, Jiang WQ, Huang HQ, Xu RH, Lin TY, Xia ZJ, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr 01; 22(4):401-3. PubMed ID: 12703998
    [Abstract] [Full Text] [Related]

  • 16. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
    Zinzani PL, Martelli M, Magagnoli M, Zaja F, Storti S, Pavone E, Lauta VM, De Renzo A, Gobbi M, Bocchia M, Ronconi F, Scaramucci L, Gherlinzoni F, Palombi F, Bendandi M, Stefoni V, Anticoli Borza P, Cellini C, Mandelli F, Tura S.
    Haematologica; 1999 Nov 01; 84(11):996-1001. PubMed ID: 10553159
    [Abstract] [Full Text] [Related]

  • 17. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
    He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ.
    Ai Zheng; 2006 Dec 01; 25(12):1538-42. PubMed ID: 17166382
    [Abstract] [Full Text] [Related]

  • 18. Brief induction chemotherapy followed by involved-field irradiation for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma.
    Ohnoshi T, Hayashi K, Mizuta J, Tagawa S, Matsutomo S, Saito S, Kawashima K, Akagi T, Kimura I.
    Int J Hematol; 1993 Jan 01; 57(1):61-6. PubMed ID: 7682860
    [Abstract] [Full Text] [Related]

  • 19. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
    Mohammadianpanah M, Ahmadloo N, Mozaffari MA, Mosleh-Shirazi MA, Omidvari S, Mosalaei A.
    Ann Hematol; 2009 May 01; 88(5):441-7. PubMed ID: 18931844
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F, Terruzzi E, Perego D, Miccolis I, Rivolta F, Manca E, Pogliani EM.
    Cancer; 2004 Jan 15; 100(2):350-5. PubMed ID: 14716771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.